Trial intelligence / Profile preview

Genetic background and stool frequency changes with linaclotide and elobixibat in chronic constipation

jRCT1041200023Recruiting

Start
Jun 2020
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of linaclotide and elobixibat in chronic constipation. Primary endpoint: Primary. Started Jun 2020; status: recruiting.

02

Drugs

linaclotideelobixibat
03

Conditions

chronic constipation

Beyond the preview

Go deeper on jRCT1041200023.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1041200023.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call